Mondias Natural Products Inc. announced that the Company has successfully completed the initial research studies previously announced with Premier Tech. Premier Tech efficacy results for CELEXT07 confirm that the product has potential as a biocontrol and bio-stimulant agent. As part of the research agreement, Premier Tech has shared study results with Mondias and both parties have completed the 180-day exclusivity period. In addition, both parties have agreed to extend their research collaboration to confirm Mondias' results and protocol on the use of CELEXT07 as a bio-stimulant in medicinal crops under greenhouse conditions.